Kidney Disease News and Research

RSS

CKD children with lower socio-economic status less likely to grow to normal height ranges

Even with more prescriptions for growth hormone, children and adolescents with chronic kidney disease were less likely to grow to normal height ranges if they came from lower-income families, according to research funded by the National Institutes of Health. Results from the Chronic Kidney Disease in Children Study are published in the December issue of the American Journal of Kidney Diseases and online today at http://www.ajkd.org.

22 Nov 2013

Scientists at Salk Institute develop novel platform to study kidney diseases

Diseases affecting the kidneys represent a major and unsolved health issue worldwide. The kidneys rarely recover function once they are damaged by disease, highlighting the urgent need for better knowledge of kidney development and physiology.

19 Nov 2013

Grave prognosis for heart patients with treatment-resistant hypertension

Patients with coronary artery disease have a particularly high risk for poor outcomes if they have treatment-resistant hypertension, shows an analysis of the Treating to New Targets trial.

18 Nov 2013

Researchers generate three-dimensional kidney structures from human stem cells

18 Nov 2013

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

New research from the Cleveland Clinic shows most patients with diabetes and obesity who undergo gastric bypass not only experience remission of their diabetes and lose significant weight, but they also reduce their risk of having a heart attack by 40 percent and their risk for suffering a stroke by 42 percent, over a 10-year time horizon.

16 Nov 2013

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

One of the most devastating side effects of diabetes is kidney failure, and one of the earliest signs of kidney damage is a disruption of the organ's filtering capacity. Diabetes patients who develop kidney failure must go on dialysis, seriously limiting their quality of life and placing them at significantly increased risk of death. The incidence of kidney disease is increasing with rising rates of obesity-associated type 2 diabetes, but very little progress has been made towards protecting the kidney's filter barrier during the past 50 years.

16 Nov 2013

Satellite Healthcare, NKF partner to sponsor free Community Kidney Disease Symposium

Satellite Healthcare, one of the nation's first and leading not-for-profit providers of kidney dialysis services and a major sponsor of kidney research, is proud to announce that it has partnered with the National Kidney Foundation to sponsor NKF's free Community Kidney Disease Symposium this Saturday, November 16th in Stockton, California.

16 Nov 2013

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

OPKO Health, Inc., has completed patient recruitment in the first phase 3 trial of Rayaldy to treat patients with secondary hyperparathyroidism, stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

16 Nov 2013

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

15 Nov 2013

Skeletal problems now added to list of diabetes complications

The list of complications from type 2 diabetes is long: vascular and heart disease, eye problems, nerve damage, kidney disease, hearing problems and Alzheimer's disease. Physicians have long thought of osteoporosis as another outcome. Based on a Mayo Clinic study published in the Journal of Bone and Mineral Research, that's confirmed: You can definitely add skeletal problems to that list.

14 Nov 2013

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.

13 Nov 2013

African Americans with APOL1 gene variant experience faster progression of CKD

A large study co-authored by Penn Medicine published this week in the New England Journal of Medicine found that African Americans with the APOL1 gene variant experience faster progression of chronic kidney disease and have a significantly increased risk of kidney failure, regardless of their diabetes status.

13 Nov 2013

Shield Therapeutics files IND application with FDA to initiate ST10 Phase 3 study

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.

12 Nov 2013

Patients' quality of life negatively affected by perceived discrimination, mistrust in health care

Perceived discrimination and mistrust in health care can negatively affect patients' quality of life, according to a study that will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA.

11 Nov 2013

Treatment with rheumatoid arthritis drug saved transplanted kidney and achieved remission

A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure.

11 Nov 2013

Genetic factors put African Americans with CKD at greater risk for end-stage renal disease

Genetic factors in African Americans with chronic kidney disease put them at a greater risk for end-stage renal disease compared to white Americans, according to a new study released today in the New England Journal of Medicine.

11 Nov 2013

New evidence shows particulate matter exposure associated with kidney damage

Many first responders working at Ground Zero following the 9/11 tragedy were exposed to cement dust, smoke, glass fibers, and heavy metals. Exposure to high levels of such particulate matter caused significant damage to first responders' kidneys, according to research presented at ASN Kidney Week 2013 November 9 at the Georgia World Congress Center in Atlanta, GA.

11 Nov 2013

Triferic drug is effective in preventing iron deficiency in patients with chronic kidney disease

Doctors at the North Shore-LIJ Health System on Saturday will present late-breaking data showing that an investigational drug Triferic is well tolerated and effective in treating iron deficiency in patients with chronic kidney disease undergoing dialysis.

11 Nov 2013

Studies highlight potential negative effects of soft drinks, sugar on kidney health

Two new studies highlight the potential negative effects that soft drinks and sugar can have on kidney health. Results of these studies will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA.

11 Nov 2013

Study: Preeclampsia during pregnancy may be associated with increased risk of kidney failure

Preeclampsia during pregnancy may be associated with an increased risk of developing kidney failure, according to a study that will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA.

11 Nov 2013

Kidney Disease News and Research

CKD children with lower socio-economic status less likely to grow to normal height ranges

Scientists at Salk Institute develop novel platform to study kidney diseases

Grave prognosis for heart patients with treatment-resistant hypertension

Researchers generate three-dimensional kidney structures from human stem cells

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

Satellite Healthcare, NKF partner to sponsor free Community Kidney Disease Symposium

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

Skeletal problems now added to list of diabetes complications

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

African Americans with APOL1 gene variant experience faster progression of CKD

Shield Therapeutics files IND application with FDA to initiate ST10 Phase 3 study

Patients' quality of life negatively affected by perceived discrimination, mistrust in health care

Treatment with rheumatoid arthritis drug saved transplanted kidney and achieved remission

Genetic factors put African Americans with CKD at greater risk for end-stage renal disease

New evidence shows particulate matter exposure associated with kidney damage

Triferic drug is effective in preventing iron deficiency in patients with chronic kidney disease

Studies highlight potential negative effects of soft drinks, sugar on kidney health

Study: Preeclampsia during pregnancy may be associated with increased risk of kidney failure

Free guide - Everything about renal proximal tubule cells eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News